Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ: DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.

The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.67
+7.94 (3.80%)
AAPL  264.24
+0.49 (0.19%)
AMD  197.42
+6.47 (3.39%)
BAC  49.88
-0.09 (-0.19%)
GOOG  304.88
+1.32 (0.43%)
META  670.10
+15.02 (2.29%)
MSFT  404.71
+0.78 (0.19%)
NVDA  183.07
+3.02 (1.68%)
ORCL  152.53
+3.53 (2.37%)
TSLA  406.99
+14.56 (3.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.